HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

W C Darbonne Selected Research

DMUC5754A

11/2016Phase I study of safety and pharmacokinetics of the anti-MUC16 antibody-drug conjugate DMUC5754A in patients with platinum-resistant ovarian cancer or unresectable pancreatic cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


W C Darbonne Research Topics

Disease

1Ovarian Neoplasms (Ovarian Cancer)
11/2016
1Pancreatic Neoplasms (Pancreatic Cancer)
11/2016
1Neoplasms (Cancer)
11/2016
1Histoplasmosis
07/2000
1Infections
07/2000

Drug/Important Bio-Agent (IBA)

1DMUC5754AIBA
11/2016
1CR 6IBA
11/2016
1AntigensIBA
11/2016
1PlatinumIBA
11/2016
1Immunoconjugates (Immunoconjugate)IBA
11/2016
1Immunoglobulin G (IgG)IBA
07/2000
1Interferon-gamma (Interferon, gamma)IBA
07/2000